Hip decompression combined with bone marrow concentrate and platelet-rich plasma for corticosteroid-induced osteonecrosis of the femoral head: mid-term update from a prospective study

Aims: Bone marrow-derived mesenchymal stem cells obtained from bone marrow aspirate concentrate (BMAC) with platelet-rich plasma (PRP), has been used as an adjuvant to hip decompression. Early results have shown promise for hip preservation in patients with osteonecrosis (ON) of the femoral head. Th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Matthew T. Houdek, Cody C. Wyles, John-Rudolph H. Smith, Andre Terzic, Atta Behfar, Rafael J. Sierra
Formato: article
Lenguaje:EN
Publicado: The British Editorial Society of Bone & Joint Surgery 2021
Materias:
mri
Acceso en línea:https://doaj.org/article/cd4ffb8562d34f23840d31cc407b0ef7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cd4ffb8562d34f23840d31cc407b0ef7
record_format dspace
spelling oai:doaj.org-article:cd4ffb8562d34f23840d31cc407b0ef72021-12-01T18:44:47ZHip decompression combined with bone marrow concentrate and platelet-rich plasma for corticosteroid-induced osteonecrosis of the femoral head: mid-term update from a prospective study2633-146210.1302/2633-1462.211.BJO-2021-0132.R1https://doaj.org/article/cd4ffb8562d34f23840d31cc407b0ef72021-11-01T00:00:00Zhttps://online.boneandjoint.org.uk/doi/epdf/10.1302/2633-1462.211.BJO-2021-0132.R1https://doaj.org/toc/2633-1462Aims: Bone marrow-derived mesenchymal stem cells obtained from bone marrow aspirate concentrate (BMAC) with platelet-rich plasma (PRP), has been used as an adjuvant to hip decompression. Early results have shown promise for hip preservation in patients with osteonecrosis (ON) of the femoral head. The purpose of the current study is to examine the mid-term outcome of this treatment in patients with precollapse corticosteroid-induced ON of the femoral head. Methods: In all, 22 patients (35 hips; 11 males and 11 females) with precollapse corticosteroid-induced ON of the femoral head underwent hip decompression combined with BMAC and PRP. Mean age and BMI were 43 years (SD 12) and 31 kg/m² (SD 6), respectively, at the time of surgery. Survivorship free from femoral head collapse and total hip arthroplasty (THA) and risk factors for progression were evaluated at minimum five-years of clinical follow-up with a mean follow-up of seven years (5 to 8). Results: Survivorship free from femoral head collapse and THA for any reason was 84% and 67% at seven years postoperatively, respectively. Risk factors for conversion to THA included a high preoperative modified Kerboul angle (grade 3 or 4) based on preoperative MRI (hazard ratio (HR) 3.96; p = 0.047) and corticosteroid use at the time of decompression (HR 4.15; p = 0.039). The seven-year survivorship for patients with grade 1 or 2 Kerboul angles for conversion to THA for articular collapse, and THA for any reason, were 96% and 72%, respectively, versus THA for articular collapse and THA for any reason in patients with grade 3 or 4 Kerboul angles of 40% (p = 0.003) and 40% (p = 0.032). Conclusion: At seven years, hip decompression augmented with BMAC and PRP provided a 67% survivorship free from THA in patients with corticosteroid-induced ON. Ideal candidates for this procedure are patients with low preoperative Kerboul angles and can stop corticosteroid treatment prior to decompression. Cite this article: Bone Jt Open 2021;2(11):926–931.Matthew T. HoudekCody C. WylesJohn-Rudolph H. SmithAndre TerzicAtta BehfarRafael J. SierraThe British Editorial Society of Bone & Joint Surgeryarticleosteonecrosisfemoral headhip preservationbone marrow derived stem cellsplatelet-rich plasma (prp)hipscorticosteroid-induced osteonecrosis of the femoral headbone marrowfemoral headbone marrow aspirate concentrate (bmac)corticosteroidsfemoral head collapsetotal hip arthroplasty (tha)mriOrthopedic surgeryRD701-811ENBone & Joint Open, Vol 2, Iss 11, Pp 926-931 (2021)
institution DOAJ
collection DOAJ
language EN
topic osteonecrosis
femoral head
hip preservation
bone marrow derived stem cells
platelet-rich plasma (prp)
hips
corticosteroid-induced osteonecrosis of the femoral head
bone marrow
femoral head
bone marrow aspirate concentrate (bmac)
corticosteroids
femoral head collapse
total hip arthroplasty (tha)
mri
Orthopedic surgery
RD701-811
spellingShingle osteonecrosis
femoral head
hip preservation
bone marrow derived stem cells
platelet-rich plasma (prp)
hips
corticosteroid-induced osteonecrosis of the femoral head
bone marrow
femoral head
bone marrow aspirate concentrate (bmac)
corticosteroids
femoral head collapse
total hip arthroplasty (tha)
mri
Orthopedic surgery
RD701-811
Matthew T. Houdek
Cody C. Wyles
John-Rudolph H. Smith
Andre Terzic
Atta Behfar
Rafael J. Sierra
Hip decompression combined with bone marrow concentrate and platelet-rich plasma for corticosteroid-induced osteonecrosis of the femoral head: mid-term update from a prospective study
description Aims: Bone marrow-derived mesenchymal stem cells obtained from bone marrow aspirate concentrate (BMAC) with platelet-rich plasma (PRP), has been used as an adjuvant to hip decompression. Early results have shown promise for hip preservation in patients with osteonecrosis (ON) of the femoral head. The purpose of the current study is to examine the mid-term outcome of this treatment in patients with precollapse corticosteroid-induced ON of the femoral head. Methods: In all, 22 patients (35 hips; 11 males and 11 females) with precollapse corticosteroid-induced ON of the femoral head underwent hip decompression combined with BMAC and PRP. Mean age and BMI were 43 years (SD 12) and 31 kg/m² (SD 6), respectively, at the time of surgery. Survivorship free from femoral head collapse and total hip arthroplasty (THA) and risk factors for progression were evaluated at minimum five-years of clinical follow-up with a mean follow-up of seven years (5 to 8). Results: Survivorship free from femoral head collapse and THA for any reason was 84% and 67% at seven years postoperatively, respectively. Risk factors for conversion to THA included a high preoperative modified Kerboul angle (grade 3 or 4) based on preoperative MRI (hazard ratio (HR) 3.96; p = 0.047) and corticosteroid use at the time of decompression (HR 4.15; p = 0.039). The seven-year survivorship for patients with grade 1 or 2 Kerboul angles for conversion to THA for articular collapse, and THA for any reason, were 96% and 72%, respectively, versus THA for articular collapse and THA for any reason in patients with grade 3 or 4 Kerboul angles of 40% (p = 0.003) and 40% (p = 0.032). Conclusion: At seven years, hip decompression augmented with BMAC and PRP provided a 67% survivorship free from THA in patients with corticosteroid-induced ON. Ideal candidates for this procedure are patients with low preoperative Kerboul angles and can stop corticosteroid treatment prior to decompression. Cite this article: Bone Jt Open 2021;2(11):926–931.
format article
author Matthew T. Houdek
Cody C. Wyles
John-Rudolph H. Smith
Andre Terzic
Atta Behfar
Rafael J. Sierra
author_facet Matthew T. Houdek
Cody C. Wyles
John-Rudolph H. Smith
Andre Terzic
Atta Behfar
Rafael J. Sierra
author_sort Matthew T. Houdek
title Hip decompression combined with bone marrow concentrate and platelet-rich plasma for corticosteroid-induced osteonecrosis of the femoral head: mid-term update from a prospective study
title_short Hip decompression combined with bone marrow concentrate and platelet-rich plasma for corticosteroid-induced osteonecrosis of the femoral head: mid-term update from a prospective study
title_full Hip decompression combined with bone marrow concentrate and platelet-rich plasma for corticosteroid-induced osteonecrosis of the femoral head: mid-term update from a prospective study
title_fullStr Hip decompression combined with bone marrow concentrate and platelet-rich plasma for corticosteroid-induced osteonecrosis of the femoral head: mid-term update from a prospective study
title_full_unstemmed Hip decompression combined with bone marrow concentrate and platelet-rich plasma for corticosteroid-induced osteonecrosis of the femoral head: mid-term update from a prospective study
title_sort hip decompression combined with bone marrow concentrate and platelet-rich plasma for corticosteroid-induced osteonecrosis of the femoral head: mid-term update from a prospective study
publisher The British Editorial Society of Bone & Joint Surgery
publishDate 2021
url https://doaj.org/article/cd4ffb8562d34f23840d31cc407b0ef7
work_keys_str_mv AT matthewthoudek hipdecompressioncombinedwithbonemarrowconcentrateandplateletrichplasmaforcorticosteroidinducedosteonecrosisofthefemoralheadmidtermupdatefromaprospectivestudy
AT codycwyles hipdecompressioncombinedwithbonemarrowconcentrateandplateletrichplasmaforcorticosteroidinducedosteonecrosisofthefemoralheadmidtermupdatefromaprospectivestudy
AT johnrudolphhsmith hipdecompressioncombinedwithbonemarrowconcentrateandplateletrichplasmaforcorticosteroidinducedosteonecrosisofthefemoralheadmidtermupdatefromaprospectivestudy
AT andreterzic hipdecompressioncombinedwithbonemarrowconcentrateandplateletrichplasmaforcorticosteroidinducedosteonecrosisofthefemoralheadmidtermupdatefromaprospectivestudy
AT attabehfar hipdecompressioncombinedwithbonemarrowconcentrateandplateletrichplasmaforcorticosteroidinducedosteonecrosisofthefemoralheadmidtermupdatefromaprospectivestudy
AT rafaeljsierra hipdecompressioncombinedwithbonemarrowconcentrateandplateletrichplasmaforcorticosteroidinducedosteonecrosisofthefemoralheadmidtermupdatefromaprospectivestudy
_version_ 1718404721049337856